ResMed Inc. (RMD.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
As of 10:17AM AEST. Market open.
| Previous close | 27.63 |
| Open | 27.73 |
| Bid | 28.09 x 51100 |
| Ask | 28.08 x 25600 |
| Day's range | 27.65 - 28.18 |
| 52-week range | 21.14 - 36.37 |
| Volume | |
| Avg. volume | 1,929,574 |
| Market cap | 41.376B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 29.93 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.29 (1.05%) |
| Ex-dividend date | 07 Feb 2024 |
| 1y target est | N/A |
- Investor's Business Daily
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.
- Zacks
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Investor's Business Daily
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
Eli Lilly stock popped Wednesday after the company's weight-loss drug significantly reduced nighttime sleep apnea events.
© 2024 Yahoo. All rights reserved.